Analysis Article • 5h
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 16, 2026
DataAggregated Company Financials
Companies9
- 7D-1.4%
- 3M2.2%
- 1Y21.5%
- YTD4.1%
Over the last 7 days, the Pharma industry has dropped 1.4%, driven by Merck KGaA declining 3.5%. In the past year, the industry has gained 21%. Earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 16 Jun 2026 | €96.5b | €67.4b | €482.5m | 22.8x | 200x | 1.4x |
| Thu, 14 May 2026 | €93.2b | €67.5b | €575.3m | 18.9x | 162x | 1.4x |
| Sat, 11 Apr 2026 | €91.1b | €67.9b | -€883,890,069.56 | 18.3x | -103x | 1.3x |
| Mon, 09 Mar 2026 | €86.4b | €67.9b | -€902,794,919.14 | 18.1x | -95.7x | 1.3x |
| Wed, 04 Feb 2026 | €100.5b | €68.3b | €2.9b | 17.1x | 35.1x | 1.5x |
| Fri, 02 Jan 2026 | €92.6b | €68.3b | €2.9b | 18.1x | 32.3x | 1.4x |
| Sun, 30 Nov 2025 | €83.6b | €68.5b | €2.9b | 17.5x | 29x | 1.2x |
| Tue, 28 Oct 2025 | €79.9b | €68.8b | -€439,054,716.76 | 19.1x | -181.9x | 1.2x |
| Thu, 25 Sep 2025 | €77.1b | €68.8b | -€438,193,335.14 | 17.9x | -175.9x | 1.1x |
| Sat, 23 Aug 2025 | €79.9b | €68.9b | -€409,723,954.92 | 17.5x | -195.1x | 1.2x |
| Mon, 21 Jul 2025 | €77.7b | €69.4b | -€283,071,598.00 | 17.4x | -274.5x | 1.1x |
| Wed, 18 Jun 2025 | €77.9b | €69.4b | -€206,268,848.00 | 17.8x | -377.8x | 1.1x |
| Fri, 16 May 2025 | €75.2b | €69.4b | -€206,564,479.00 | 18.1x | -363.9x | 1.1x |
| Sun, 13 Apr 2025 | €72.5b | €69.3b | €467.0m | 17.7x | 155.2x | 1x |
| Tue, 11 Mar 2025 | €84.3b | €69.2b | €436.0m | 21.1x | 193.4x | 1.2x |
| Thu, 06 Feb 2025 | €84.9b | €69.2b | €2.0b | 22.8x | 41.9x | 1.2x |
| Sat, 04 Jan 2025 | €82.3b | €69.2b | €2.0b | 22.6x | 41x | 1.2x |
| Mon, 02 Dec 2024 | €83.1b | €69.2b | €2.0b | 21.4x | 41x | 1.2x |
| Wed, 30 Oct 2024 | €93.6b | €69.4b | €1.6b | 20.6x | 60x | 1.3x |
| Fri, 27 Sep 2024 | €100.6b | €69.4b | €1.5b | 24.6x | 68.3x | 1.5x |
| Sun, 25 Aug 2024 | €104.4b | €69.3b | €1.5b | 31.2x | 71.6x | 1.5x |
| Tue, 23 Jul 2024 | €94.5b | €69.2b | -€303,627,757.00 | 29x | -311.4x | 1.4x |
| Thu, 20 Jun 2024 | €98.9b | €69.2b | -€328,028,608.00 | 26.2x | -301.6x | 1.4x |
| Sat, 18 May 2024 | €103.4b | €69.2b | -€312,802,180.00 | 21.7x | -330.5x | 1.5x |
| Mon, 15 Apr 2024 | €95.7b | €70.0b | -€34,208,180.00 | 20.8x | -2796.8x | 1.4x |
| Wed, 13 Mar 2024 | €98.7b | €70.0b | €6.5m | 20x | 15196.9x | 1.4x |
| Fri, 09 Feb 2024 | €95.5b | €70.6b | -€650,504,143.00 | 19.5x | -146.8x | 1.4x |
| Sun, 07 Jan 2024 | €99.2b | €70.6b | -€650,504,143.00 | 20x | -152.5x | 1.4x |
| Tue, 05 Dec 2023 | €103.3b | €70.6b | -€650,606,256.00 | 18.9x | -158.8x | 1.5x |
| Thu, 02 Nov 2023 | €104.3b | €72.1b | €4.7b | 17.2x | 22.3x | 1.4x |
| Sat, 30 Sep 2023 | €116.1b | €72.1b | €4.7b | 22x | 24.8x | 1.6x |
| Mon, 28 Aug 2023 | €122.1b | €72.1b | €4.7b | 22.6x | 26.2x | 1.7x |
| Wed, 26 Jul 2023 | €122.1b | €74.1b | €6.5b | 18.9x | 18.9x | 1.6x |
| Fri, 23 Jun 2023 | €119.1b | €74.1b | €6.4b | 20.5x | 18.6x | 1.6x |
Price to Earnings Ratio
18.6x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 200x which is higher than its 3-year average PE of 130x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.72% | |
| Healthcare | 0.0076% | |
| Pharma | -1.44% | |
| Pharma | -1.44% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €36.31 | 1.7% +€609.1m | 31.7% | PS0.8x | |
| DMP Dermapharm Holding | €47.95 | 2.0% +€47.1m | 34.3% | PE16.5x | |
| 93M1 MPH Health Care | €27.30 | 4.2% +€4.7m | 40.0% | PS2.3x | |
| 27N0 Cannovum Cannabis | €0.46 | 13.5% +€127.1k | 147.8% | n/a |